Robert D Bona MD
Clotting Disorder, Hemophilia & Bleeding Disorder
Professor of Medicine Yale School of Medicine Director Classical Hematology Program- Department of Medicine Medical Director (adult) Hemophilia Treatment Center
Join to view full profile
Yale New Haven HispitalHematologyNew Haven, CT 06519
Phone+1 203-200-3634
Dr. Bona is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Bona is a hematologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. He received his medical degree from SUNY Upstate Medical University and has been in practice 37 years. He specializes in clotting disorder and hemophilia & bleeding disorder and is experienced in thrombotic disorders, bleeding disorders, general / benign hematology, and transfusion medicine.
Education & Training
University of ConnecticutFellowship, Hematology and Medical Oncology, 1983 - 1986
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1980 - 1983
SUNY Upstate Medical UniversityClass of 1980
Certifications & Licensure
CT State Medical License 1984 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsEmicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis.Samira Glaeser-Khan, Satoko Ito, Manraj Sra, Rhys Richmond, Robert D Bona
Blood Advances. 2025-12-23 - 1 citationsSuccessful treatment of Kimura disease with Mycophenolate Mofetil: a report of two cases and review of the literature.Mikaela Wilson, Cyrus C Hsia, Kevin Rowan, Shih-Han Susan Huang, Tony Ng
Rheumatology International. 2025-09-09 - 2 citationsProphylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.Satoko Ito, Kunal C Potnis, Jessica Preston Harvey, Manraj Sra, Jan Phillipp Bewersdorf
Annals of Internal Medicine. 2025-06-01
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023- Covishield Side Effects: What's TTS Syndrome, Symptoms, and Danger Signs You Shouldn't IgnoreApril 30th, 2024
- Fact Check: Are Indians Who Got Covishield Vaccine Susceptible to TTS?May 2nd, 2024
Grant Support
- HIV On Hepatitis CNational Center For Research Resources2008
- Complication Of Hemophilia And Serum Testing And StorageNational Center For Research Resources2004–2008
- Universal Data And Serum Specimen Collection System For HemophiliaNational Center For Research Resources2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
